FC3R Project:

The FC3R aims to replace the use of antibodies of animal origin, which present both ethical and scientific robustness problems (variability, lack of reproducibility, etc.). In partnership with the Association Française d’Histotechnologie (AFH) and antibody suppliers, a pilot study was carried out to characterise the performance of alternative recombinant antibodies and share the results with the scientific community. Learn more about this project characterising and validating recombinant alternatives here.

Centre for Human Specific Research Database:

The Recombinant Antibodies & Mimetics Database strives to raise awareness among researchers while encouraging suppliers to adopt innovative, scientifically advanced, and ethically sustainable technologies. By positioning recombinant antibodies and antibody mimetics as the new gold standard in research and development, it serves as a vital link between researchers and global suppliers, offering extensive benefits to both.